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Nanofibrous Collagen Nerve Conduits
for Spinal Cord Repair
Ting Liu, M.D.,1 John D. Houle, Ph.D.,2 Jinye Xu, M.Eng.,3 Barbara P. Chan, Ph.D.,3 and Sing Yian Chew, Ph.D.1
Nerve regeneration in an injured spinal cord is often restricted, contributing to the devastating outcome of
neurologic impairment below the site of injury. Although implantation of tissue-engineered scaffolds has
evolved as a potential treatment method, the outcomes remain sub-optimal. One possible reason may be the lack
of topographical signals from these constructs to provide contact guidance to invading cells or regrowing axons.
Nanofibers mimic the natural extracellular matrix architecturally and may therefore promote physiologically
relevant cellular phenotypes. In this study, the potential application of electrospun collagen nanofibers (dia-
meter = 208.2 – 90.4 nm) for spinal cord injury (SCI) treatment was evaluated in vitro and in vivo. Primary rat
astrocytes and dorsal root ganglias (DRGs) were seeded on collagen-coated glass cover slips (two-dimensional
[2D] substrate controls), and randomly oriented or aligned collagen fibers to evaluate scaffold topographical
effects on astrocyte behavior and neurite outgrowth, respectively. When cultured on collagen nanofibers, as-
trocyte proliferation and expression of glial fibrillary acidic protein (GFAP) were suppressed as compared to cells
on 2D controls at days 3 ( p < 0.05) and 7 ( p < 0.01). Aligned fibers resulted in elongated astrocytes (elongation
factor > 4, p < 0.01) and directed the orientation of neurite outgrowth from DRGs along fiber axes. In the contrast,
neurites emanated radially on randomly oriented collagen fibers. By forming collagen scaffolds into spiral
tubular structures, we demonstrated the feasibility of using electrospun nanofibers for the treatment of acute SCI
using a rat hemi-section model. At days 10 and 30 postimplantation, extensive cellular penetration into the
constructs was observed regardless of fiber orientation. However, scaffolds with aligned fibers appeared more
structurally intact at day 30. ED1 immunofluorescent staining revealed macrophage invasion by day 10, which
decreased significantly by day 30. Neural fiber sprouting as evaluated by neurofilament staining was observed
as early as day 10. In addition, GFAP immunostained astrocytes were found only at the boundary of the lesion
site, and no astrocyte accumulation was observed in the implantation area at any time point. These findings
indicate the feasibility of fabricating 3D spiral constructs using electrospun collagen fibers and demonstrated the
potential of these scaffolds for SCI repair.
Introduction
Spinal cord injuries (SCIs) result in widespread loss ofaxonal connections and limited neuronal regeneration,
which typically lead to functional impairment below the site
of injury. The consequences are devastating, but unfortu-
nately, effective methods of treatment are lacking. In general,
a fluid-filled cavity typically forms at the injury site and
becomes surrounded by a dense glial scar that is composed
of astrocytes and connective tissue elements.1 Astrocytes
supply both structural and physiological support and re-
spond rapidly for neural protection or healing after injury.2,3
It was shown that reactive astrocytes play essential roles in
preserving neural tissue and restricting inflammation after
central nervous system (CNS) injury.2 However, subsequent
studies demonstrated that the inhibitory and nonpermissive
nature of glial scar prevents successful axonal regeneration
after SCI.3,4 Besides being a mechanical barrier for axonal
reconnections, the molecular composition of the glial scar
and the inhibitory molecules secreted by astrocytes also
contribute to regenerative failure.2,5 Therefore, deeper un-
derstanding of astrocytes behaviors may contribute to opti-
mal design strategies for SCI treatment.
To modulate the inhibitory environment after SCI, bioma-
terial scaffolds, particularly hydrogels, have been developed
to bridge the injury gap. However, although a degree of
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cellular penetration is often observed, nerve regeneration
remains sub-optimal.6,7 One possible reason may be the iso-
tropic nature of hydrogels. Since the spinal cord is comprised
of highly oriented neural fibers, imparting topographical cues
into scaffold designs for contact guidance may be beneficial.
The observed directed axonal regeneration from rostral and
caudal ends after SCI in the presence of implanted aligned
collagen microfilaments supports this notion.8,9
Compared to microfilaments, nanofibers more closely
mimic the size scale and architecture of the natural extra-
cellular matrix and may elicit more physiologically relevant
cellular phenotypes.10,11 Electrospun nanofiber scaffolds, in
particular, further permit control over nanofiber alignment
to provide contact guidance to seeded cells.12 In addition, it
is easy to manipulate the macroscopic structure of these
constructs for specific applications13 and to encapsulate
biomolecules14–17 for a synergistic control over cell fate. To
date, only few studies have demonstrated in vivo applica-
tions of electrospun synthetic nanofibers for nerve regener-
ation in the CNS.18–20 Due to the lack of biofunctionality
of synthetic polymers, further surface chemical modifica-
tions were often required to support neural cell function
effectively.18
In this study, we evaluated the potential of using elec-
trospun collagen nanofibers for SCI treatment. Collagen type
I plays a role in neuronal pathfinding and growth cone
guidance21 and has been shown to provide a permissive
environment for the regrowth of injured axons.22 In our
previous study, we demonstrated the feasibility of electro-
spinning collagen nanofibers by adopting acetic acid as the
solvent to decrease protein denaturation. Furthermore, by
incorporating a photochemical crosslinking process, the na-
nofiber architecture was stabilized for at least 21 days
in vitro.23 Here, we demonstrated the ability to form spiral
conduits of electrospun collagen nanofibers and the feasi-
bility of implanting these tubular constructs for the treatment
of SCI.
Materials and Methods
Materials
Type I collagen was extracted from rat tails for electrospin-
ning.24 Ninety-nine percent acetic acid was purchased from
Merck. Dulbecco’s modified Eagle’s medium (DMEM), mini-
mum essential medium (MEM), neural basal medium, B27,
l-glutamine, penicillin–streptomycin, 4¢,6-diamidino-2-pheny-
lindole (DAPI), antiglial fibrillary acidic protein (anti-GFAP),
anti-ED1, anti-Tuj1, secondary antibodies, green-fluorescent
calcein-acetoxymethyl ester (AM), and 5-ethynyl-2¢-deoxyur-
idine (EdU) assay kits were purchased from Invitrogen. Fetal
bovine serum (FBS) was purchased from Hyclone. Enzyme
papain was from Worthington. Type I collagen solution was
purchased fromRocheDiagnostics for coating glass cover-slips
as two-dimensional (2D) substrate control. Neurotrophin-3
(NT-3) was ordered fromR&DSystem.All other chemicals and
reagents were purchased from Sigma-Aldrich.
Fabrication of collagen nanofibers
and nerve guide conduits
Collagen nanofibers were electrospun as described previ-
ously.23 To obtain aligned and randomly oriented fibers,
samples were collected on aluminum foils that were moun-
ted on a grounded target that was rotating at 2500 and
*150 rpm respectively. Thereafter, all samples were photo-
chemically crosslinked as described previously.23 Spiral-
shaped nerve guide conduits were then prepared by rolling
the wet crosslinked scaffolds into tubes of 4–5 layers. After
that, all samples were critical point dried (BAL-TEC CPD
030) and the underlying aluminum foil support was re-
moved. For conduits with aligned fibers they were oriented
longitudinally when placed into the injured spinal cord.
Evaluation of structure and appearance
of nerve guide conduits
All samples were sputter-coated with platinum ( JEOL,
JFC-1600) for 90 s. Thereafter, the cross section of the conduit
and fiber morphology was observed under the scanning
electron microscope ( JEOL, JSM-6390 LA) at an accelerating
voltage of 10 kV.
Dorsal root ganglia culture and immunostaining
Dorsal root ganglias (DRGs) were dissected from E15-old
embryos of Sprague Dawley rats under current Institutional
Animal Care and Use Committee (IACUC) guidelines and
placed in L15 medium. Before seeding the DRGs, cross-
linked random and aligned collagen scaffolds were sterilized
by ultraviolet (UV) irradiation for 15min on each side and
soaked in phosphate-buffered saline (PBS) at 37C overnight
to remove any chemical residues in the scaffolds. The iso-
lated DRGs were then seeded onto sterilized collagen scaf-
folds in 24-well plates and cultured in neural basal medium
containing 1% B27, 0.5mM l-Glutamine, 1% penicillin–
streptomycin, and 40 ng/mL NT-3. Glass coverslips coated
with type I collagen were used as the 2D control. Type I
collagen solution was added on UV-sterilized glass cover-
slips at a density of 5mg/cm2 and incubated at room tem-
perature for 2 h. After that, the glass coverslips were washed
with PBS for three times and air-dried for cell seeding.
At day 2, immunostaining was conducted to observe
neurite outgrowth from DRGs that were fixed with 10%
formalin and permeabilized with 0.1% Triton X-100 for
20min. After thorough washes with PBS, the ganglia were
blocked with 3% bovine serum albumin (BSA). Primary an-
tibody against Tuj-1 (1:500) was added and incubated with
cells for 1 h at room temperature. After washing with PBS for
three times, secondary antibody (Alexa Fluor 633, 1:500) was
added. Cell nuclei were stained with DAPI (1:1000) and all
images were taken under the confocal microscope (Zeiss,
LSM 710).
Astrocyte cell culture
Primary cortical astrocytes were harvested from E18-old
rat embryos under current IACUC guidelines following es-
tablished protocol.25 The cerebral cortices were isolated from
the brains and the meninges were removed. The cortices
were then digested with papain (25U/mL). After digestion,
cells were dissociated by filtering through a 70-mm cell
strainer and collected by centrifugation. Cells were re-
suspended in MEM supplemented with 10% FBS, 2% glu-
cose, and 1% penicillin–streptomycin in cell culture plate at a
density of 2 · 105 cells/cm2. Neuronal cells were removed by
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constant agitation overnight. The culture medium was re-
placed every 2 days until the monolayer was obtained. Pri-
mary astrocytes with a purity of 99% were obtained based on
this protocol. Thereafter, astrocytes were propagated in
DMEM supplemented with 10% FBS and 1% penicillin–
streptomycin. Cells of passage 4–9 were used in this study.
Before seeding the astrocytes, crosslinked collagen scaf-
folds were sterilized and soaked in PBS in 24-well plates to
wash away any chemical residues. Thereafter, PBS was as-
pirated and astrocytes suspension were added onto the
scaffolds at a density of 104 cells/well in 24-well plates
(n = 3). Glass cover slips coated with 5 mg/cm2 of type I col-
lagen as described above were used as the 2D substrate
control. The culture medium was changed at day 3 for
samples that were collected at day 7.
Evaluation of astrocyte morphology
At days 3 and 7, the effects of substrate topography on
astrocyte morphology were evaluated by green-fluorescent
calcein-AM staining following manufacturer’s protocol. Cells
were imaged under a fluorescent microscope (Olympus IX
71) at 10· magnification. To prevent bias, eight randomly
chosen regions were imaged on each scaffold. Thereafter,
morphometric measurements were carried out using ImageJ
(NIH) and at least 100 cells were measured for each sample.
The elongation factor (E) of astrocytes was calculated as
follows: ([long axis/short axis] - 1). E describes the extent to
which the equimomental eclipse is lengthened or stretched
out.26,27 The value of E will reflect whether the astrocytes
are elongated by the contact guidance with collagen fibers.
Cell shape index, which was defined as cell perimeter2/
4p$area, was calculated as a measurement of how circular or
linear the cell was (where 1.0 indicates a rounded cell and
a larger value implies a more dendritic cell shape).28 Acti-
vated astrocytes are commonly recognized morphologically
by converting from flat, polygonal cells to contracted and
highly branched cells. Cell shape index, which is also
named as dendritic index, may reflect the activated state of
astrocytes.29
Evaluation of astrocyte proliferation
Astrocyte proliferation in response to substrate topogra-
phy was quantified by measuring DNA synthesis using EdU
incorporation assay following manufacturer’s protocol. At
days 3 and 7, EdU was added into the cell culture medium
for 18 h. Thereafter, all samples were fixed in 10% formalin
and permeabilized with 0.1% Triton X-100 for 20min. For
EdU detection, the click-it reaction was performed according
to the manufacturer’s instructions. To calculate EdU incor-
poration rate, 9 images were taken at different regions and at
least 200 cells were counted for each sample.
Evaluation of GFAP expression in astrocytes
Immunostaining was conducted at days 3 and 7 to observe
the expression levels of GFAP in astrocytes seeded on dif-
ferent substrates. Scaffolds seeded with cells were fixed and
permeabilized as the protocol described previously. After
thorough washes with PBS, the scaffolds were blocked with
3% BSA. Primary antibodies against GFAP (1:500) were ad-
ded and incubated with cells for 1 h at room temperature.
After washing with PBS for three times, secondary antibody
(Alexa Fluor 633, 1:500) was added and cell nuclei were
labeled with DAPI (1:1000). All images were taken by using
the same settings under a Zeiss confocal microscope (LSM
710). To calculate fluorescence intensity of GFAP, 24 sepa-
rate images were taken at different regions and at least 100
cells were analyzed. The fluorescence intensity of GFAP
was quantified by a modified protocol.30 Briefly, after
converting to eight-bit images, the shape of each cell was
outlined and single-cell fluorescent intensity was measured
by ImageJ.
In vivo studies: hemisection SCI model
The care and use of laboratory animals and all surgical
procedures followed the guidelines by the National Institute
of Health and Drexel University College of Medicine IACUC.
Eight adult female Sprague Dawley rats (225–250 g) were
anesthetized under isoflurane delivered at a flow rate of
0.2 L/min. A cervical level 3 (C3) complete unilateral hemi-
section (Hx) lesion cavity of 2.5mm in length was then cre-
ated by aspiration. Thereafter, UV-sterilized collagen tubes
(2.5mm in length, 2mm in diameter) were implanted into
the injury site. The animals were implanted with either
random (n = 3) or aligned collagen scaffolds (n = 5). For all
samples, the longitudinal axis of the conduit was parallel to
the long axis of the spinal cord.
To evaluate the in vivo stability of the collagen scaffolds,
10- and 30-day time points were chosen. At day 10, three
animals (random, n = 1; aligned, n= 2) were euthanized with
an overdose of Euthasol (390mg/kg pentobarbital and
50mg/kg phenytoin, intraperitoneal) and perfused trans-
cardially with 4% paraformaldehyde in 0.1M Sorenson’s
phosphate buffer. The remaining animals (random, n = 2;
aligned, n = 3) were sacrificed and perfused by the same way
at day 30. The C3 spinal cord surrounding the lesion site was
then removed, postfixed at 4C for 4 h, and submersed in
20% sucrose for 24 h at 4C. Cryostat sections at 25mm in
both transverse and longitudinal planes were prepared for
immunofluorescent staining.
Immunofluorescent staining of spinal cord sections
Slides were stored at - 80C until immunostaining was
performed. Sections were incubated in phosphate buffered
4% paraformaldehyde for 15min and then washed with
0.1M Sorenson’s phosphate buffer before being permeabi-
lized in Triton X-100 PBS (T-PBS) for 15min. After thorough
washes in PBS, the sections were blocked for nonspecific
reactivity with normal goat serum/T-PBS (1:20) for 15min.
Primary antibodies were applied to the sections and incu-
bated overnight at room temperature. The primary anti-
bodies were against the following: ED1 (recognizing
marcrophages, 1:1000), Neurofilament (recognizing neurons,
1:400), and GFAP (recognizing astrocytes, 1: 1000). GFAP and
ED1 were double labeled on slides. After washing with
Sorenson’s phosphate buffer, slides labeled for GFAP and
neurofilament were incubated with Alexa fluor 488 goat anti-
rabbilt antibody (at 1:1000 dilution). Slides labeled with ED1
were incubated Texas Red rabbit anti-mouse antibody (at
1:1000 dilution) for 90min. All slides were coverslipped with
fluoromount mounting medium and examined under the
confocal microscope at 10 · and 20· magnifications.
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To examine the in vivo stability of collagen scaffolds
and the extent of tissue–implant integration, Masson’s tri-
chrome staining was conducted (Biopolis Shared Facilities–
Histology, Biomedical Sciences Institutes, Singapore).
Thereafter, all samples were examined using a light micro-
scope (Olympus, IX71).
Statistic analysis
All data presented in this study are expressed as mean –
standard error (SE) of mean. For the analyses of elongation
factor and cell shape index, Mann–Whitney U test was used.
One-way analysis of variance was used to analyze EdU in-
corporation rate of astrocytes and the fluorescent intensity of
GFAP expressed on random, aligned collagen nanofibers and
collagen-coated glass cover slips. Independent-samples t-test
(SPSS Statistics 17.0) was used for comparing GFAP intensity
differences between day 3 and 7 on different substrates. Er-
ror bar represents the SE of the mean.
Results
Morphology and appearance of electrospun collagen
fibers and nerve guide conduits
Figure 1a and b illustrate the architecture of photochemi-
cally crosslinked electrospun collagen scaffolds that are
comprised of aligned and randomly oriented nanofibers,
respectively. Uniform nanofibers with an average diameter
of 208.2– 90.4 nm were obtained in both conditions. Re-
gardless of fiber orientation, all collagen conduits looked
similar macroscopically, and as shown in Figure 1c, the cross
section of the nerve guide conduits revealed a spiral struc-
ture that comprised of 4–5 layers of nanofiber scaffold.
DRG neurite outgrowth
As shown in Figure 2a, the neurite outgrowth from DRG
explants followed the orientation of aligned collagen fibers.
In contrast, neurites emanated radially from DRG tissues
that were cultured on randomly oriented collagen fibers and
collagen-coated glass cover slips, generating a rounded ap-
pearance (Fig. 2b, c).
Astrocytes morphology
As shown in Figure 3a, astrocytes responded to the
aligned nanofiber architecture and exhibited elongated
morphology. In contrast, astrocytes spread and adopted
nonspecific orientations on randomly oriented fibers and
collagen-coated glass cover slips (Fig. 3b, c). Correspond-
ingly, the elongation factor and cell shape index of astrocytes
were significantly higher on aligned fibers, while no signifi-
cant difference was found between randomly oriented fibers
and 2D controls (Fig. 3d, e).
Astrocytes proliferation
On day 3, the proliferation of astrocytes was significantly
lower on collagen nanofibers than on 2D controls (Fig. 4,
p < 0.05). No significant difference was detected in response
to fiber orientation. On day 7, no EdU incorporation was
found in astrocytes that were seeded on collagen substrates.
On the other hand, EdU incorporation decreased to
18.9% – 8.1% on collagen-coated cover slips ( p < 0.01).
Astrocytes GFAP expression
As indicated in Figure 5, GFAP signal intensity was sig-
nificantly higher in astrocytes that were cultured on 2D
controls than collagen nanofiber substrates on days 3 and 7
( p< 0.05 and p< 0.01, respectively; Fig. 5g). However, there
was no significant difference between randomly oriented
and aligned fibers. On day 7, the signal intensity decreased
significantly on collagen scaffolds ( p < 0.05), while no sig-
nificant alteration was found on collagen-coated cover slips.
Collagen scaffold in vivo stability and biocompatibility
Figure 6 illustrates the spinal cord sections that were
stained with Masson’s trichrome, where blue staining indi-
cates collagenous material. On day 10, the collagen walls that
FIG. 1. SEM images of electrospun
collagen aligned fibers (a), random
fibers (b), and cross section of colla-
gen nerve guide conduit composed
of aligned fibers (c). SEM, scanning
electron microscopy.
FIG. 2. Tuj-1 staining of
DRG explants seeded on
aligned collagen fibers (a),
random collagen fibers (b),
and collagen-coated glass
cover slips (c). White arrow
indicates the alignment of col-
lagen fibers. Red, Tuj-1; blue,
DAPI. DRG, dorsal root gan-
glia; DAPI, 4¢,6-diamidino-2-
phenylindole. Color images
available online at www
.liebertonline.com/tea
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made up the spiral architecture remained intact as shown in
the sagittal sections of the tissues (Fig. 6a). As indicated in
Figure 6c, the spiral configuration of the collagen constructs
was retained. In general, the longitudinal axes of the spiral
conduits remained parallel to the spinal cords, demonstrat-
ing the structural stability of the conduits. However, the
orientation of the collagen walls was not strictly uniform due
to artificial sectioning defects. Significant cell penetration
was found within the walls and the interior sections of the
conduits regardless of fiber orientation (Fig. 6b, d). In gen-
eral, no significant difference was observed in host–implant
integration in response to fiber orientation and no cystic
cavity was observed in any animals.
On day 30, Masson’s trichrome staining showed decreased
presence of cells within all implants, suggesting a possible
reduction in the acute inflammatory response (Fig. 6g, h).
Figure 6e and f reveals the sagittal sections of the spinal
cord. On day 30, the walls of aligned collagen nanofiber
scaffolds remained visible. On the other hand, constructs that
comprised of randomly oriented fibers degraded and no
collagen remnant was observed in the cross sections of the
tissues (Fig. 6g, h).
Immunofluorescent staining for inflammatory
response, astrocytes accumulation,
and neural fiber sprouting
Figure 7 illustrates the immunofluorescent images of the
spinal cord sections. As shown in Figure 7a, d, g, and j, ED1
immunolabeling was used to examine the macrophage re-
sponses, which were stained as dot-like structures that ac-
cumulated at the boundary of the lesion sites. Crosslinked
collagen scaffolds demonstrated strong autofluorescence at a
wavelength of 520–570 nm due to the photo initiator (rose
bengal) that was added for crosslinking23 and appeared as
blocky patterns. On day 10, strong ED1 signals were detected
in all animals, suggesting strong inflammatory response.
However, no significant difference was observed between
randomly oriented and aligned nanofiber constructs (Fig. 7a,
d). On day 30, the ED1 signal intensity decreased signifi-
cantly in all samples. In animals that received randomly
oriented nanofiber scaffolds, a few macrophages were ob-
served at the border of the lesion areas (Fig. 7j), while no ED1
signal was observed in animals that received aligned nano-
fiber substrates (Fig. 7g).
At both time points, GFAP was not detected within the
scaffold in any of the animals. In contrast, reactive astrocytes
stained by GFAP were present at the borders of the lesion
areas (Fig. 7b, e, h, and k).
When treated with collagen scaffolds for 10 days, some
neurofilament sprouting was observed at the site of
FIG. 3. Calcein-AM
staining of astrocytes seeded
on aligned collagen fibers
(a), random collagen fibers
(b), and collagen-coated
glass cover slips (c). Elonga-
tion factor (d) and cell shape
index (e) of astrocytes see-
ded on different substrates.
n = 3, mean– SE (*p< 0.01,
Mann–Whitney U test).
AM, acetoxymethyl ester;
SE, standard error. Color
images available online at
www.liebertonline.com/tea
FIG. 4. EdU incorporation rate of astrocytes seeded on
aligned and randomly oriented collagen fibers, and collagen-
coated glass cover slips. n= 3, mean– SE (*p< 0.05, ANOVA;
**p< 0.01, independent t-test). EdU, 5-ethynyl-2¢-deoxyuridine;
ANOVA, analysis of variance.
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injury regardless of nanofiber orientation (Fig. 7c, f ).
Neurofilament was detected at the rostral and caudal
ends of the aligned samples. However, the orientation of
regenerated axons in response to fiber alignment was not
obvious at both time points. In the cross-sectional images
of constructs that comprised of randomly oriented fibers,
neurofilament was detected mainly around the outer re-
gions of the implants and limited amount of neural fibers
were observed at the middle points of the conduits
(Fig. 7f).
FIG. 5. GFAP staining of
astrocytes seeded on aligned
collagen fibers (a, d), random
collagen fibers (b, e), and
collagen-coated glass cover
slips (c, f) for 3 days (a–c) and
7 days (d–f). White arrows
indicate the alignment of
collagen fibers. Red, GFAP;
blue, DAPI. GFAP fluores-
cent intensity per cell (g).
n = 3, mean– SE (*p < 0.05,
**p< 0.01, ANOVA; X de-
notes p < 0.05, XX denotes
p < 0.01 vs. day 3, indepen-
dent t-test). GFAP, glial fi-
brillary acidic protein. Color
images available online at
www.liebertonline.com/tea
FIG. 6. Masson’s trichrome staining of spinal cord implanted with collagen scaffolds for 10 days (a–d) and 30 days (e–h).
Images of spinal cord implanted with aligned scaffolds (a, b, e, f) in a longitudinal plane and random scaffold in a transverse
plane (c, d, g, h). Higher magnification (20 · ) images of the area indicated by dash circles show cell penetration into scaffolds
(b, d, f, h). Color images available online at www.liebertonline.com/tea
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Discussion
Current SCI treatment methods remain limited due in part
to the complex inhibitory microenvironment after injuries.
An ideal tissue construct for SCI treatment should help les-
sen glial scar formation and support axon extensions. Ad-
ditionally, the scaffold should be able to direct regenerating
axons across the injury site to restore functional connections.
Currently, hydrogels are often used for scaffold implantation
treatments in SCI models.31–33 Although enhanced structural
recovery has been reported as compared to treating the in-
jury without any scaffold, nerve regeneration remains sub-
optimal. A possible reason may be the isotropic nature of
hydrogels, which lacks topographical signals for cellular
contact guidance.6,7 In contrast, nanofibers provide biomi-
micking signals and result in attraction of more physiologi-
cally relevant cellular phenotypes.34–36 Applied to neural
tissue engineering, nanofiber topography, particularly the
aligned fibers, can enhance Schwann cell maturation37,38 and
direct neurite outgrowth.39,40
Plain electrospun collagen nanofibers supported neurite
outgrowth from DRGs (Fig. 2). Presented in aligned format,
alignment of neurite outgrowth was observed. This demon-
strated the contact guidance provided by aligned nanofibers,
which is consistent with the literature.39 In addition, we
evaluated in vitro glial cell interactions with nanofibers. Al-
though equally important in the nerve regeneration process,
glial cell behavior is less extensively evaluated in neural
FIG. 7. Immunofluorescent images of
spinal cord sections implanted with collagen
scaffolds for 10 days (a–f) and 30 days (g–l).
Spinal cords were implanted with collagen
spiral conduits composing of aligned fibers
in a longitudinal plane (a–c, g–i) and ran-
domly oriented fibers in a transverse plane
(d–f, j–l). White dash line indicates lesion
border and ‘‘L’’ indicates lesion area. Spinal
cord sections were stained with ED1 (a, d, g,
j), GFAP (b, e, h, k), and NF (c, f, i, l).
ED1-positive macrophages were stained as
red dots (filled arrows). Collagen scaffolds
demonstrated strong autofluorescence
and appeared as blocky patterns (open
arrows). GFAP, green; ED1, red; NF, green.
Color images available online at www
.liebertonline.com/tea
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tissue engineering studies. In this work, we focused on as-
trocyte behavior since they are the major contributors to glial
scar formation upon activation after an injury to the CNS.41
When cultured on randomly oriented fibers, the cell shape
index of astrocytes was similar to that on collagen-coated
cover slips. Although cell shape index on aligned collagen
fibers was significantly higher, astrocytes did not demon-
strate truly ramified morphological changes. The higher cell
shape index was likely caused by the elongated morphology
in response to aligned nanofibers instead of enhanced cel-
lular activation. These results suggested that the extent of
astrocytes activation was not enhanced by nanofiber topog-
raphy in comparison to 2D controls. This was also substan-
tiated by GFAP expression analysis.
Activated astrocytes are usually characterized by hyper-
trophy, proliferation, and increased GFAP expression.42,43
However, we observed decreased astrocyte proliferation and
GFAP expression on electrospun nanofibers versus 2D col-
lagen coating. Combining our observation with prior studies
that showed alterations in astrocyte morphology and
migration and decreased proliferation in response to elec-
trospun nanofibers,39,44,45 we find that the topography of
nanofibers may have altered cell attachment, thereby
changing intracellular signaling pathways that were con-
nected with the control of cell behavior and suppressed the
expression of GFAP. Furthermore, no obvious differences in
GFAP expression were observed in astrocytes in response to
nanofiber orientation (Fig. 5). This result is consistent with
the observations by East et al., where astrocytes expressed
similar levels of GFAP regardless of fiber alignment on col-
lagen gels.46 Matrix stiffness affects cell proliferation, protein
production, cell motility, and cell fate.47,48 Decreased astro-
cytes adhesion on soft gels were observed due either to mi-
gration off the soft gel or to detachment.48 It is possible that
the in our study, matrix stiffness overrides the topographical
cues and became the predominant factor manipulating
astrocyte cell fate. Therefore, no significant difference in as-
trocytes proliferation rate and GFAP expression was ob-
served between aligned and randomly oriented fibers.
Further analyses on cell signaling pathways involved in
matrix topography and stiffness sensing by astrocytes would
provide useful information on these areas. Nonetheless, ta-
ken together, the results suggested that nanofibers may de-
crease the extent of astrocyte involvement post-SCI. Coupled
with the ability to support and direct neurite outgrowth,
electrospun collagen scaffolds may be more favorable than
collagen introduced in 2D format for SCI repair.
To explore the feasibility of implanting electrospun colla-
gen spiral nerve conduits into the spinal cord and to evaluate
the in vivo structural stability of the constructs, a short-term
acute hemi-section SCI model was chosen. By this injury,
unilateral ascending sensory axons and descending motor
axons were damaged. As a preliminary study, only a total of
8 rats were used. The 10- and 30-day endpoints were chosen
based on previous in vitro stability studies that indicated
*50% and 70% scaffold mass loss by days 7 and 15, re-
spectively.23 In addition, 30 days are thought to be sufficient
for significant neural regeneration to occur for meaningful
analyses of structural recovery.49 As revealed by Masson’s
trichrome staining, the spiral structures of all collagen nerve
conduits were retained after implantation. This indicated the
feasibility of fabricating and implanting such spiral con-
structs. At day 30, conduits that comprised of randomly
oriented fibers were almost completely degraded, while the
structure of aligned collagen tubes remained visible. Ran-
domly oriented nanofibers significantly enhance initial
monocyte adhesion as compared to aligned fibers.50 This
may partially explain the faster degradation rate of randomly
oriented collagen fiber spiral conduits. Further detailed
quantitative analyses on the extent of macrophage invasion
with respect to conduit topography using larger sample sizes
may provide useful insights.
Significant cell penetration into all collagen scaffolds was
observed as early as day 10, regardless of nanofiber orien-
tation. In contrast, cellular infiltration rarely occurred in
randomly oriented electrospun synthetic polymer fibers.50
This difference may be attributed to the more compliant
nature of collagen and its faster in vivo degradation rate.51,52
The migration of support cells into the injured site is es-
sential to induce or support tissue regeneration by provid-
ing an extracellular milieu.31 Therefore, electrospun collagen
fibers may be indicated as a preferential material for SCI
treatment.
The significant decrease in cell density and ED1-positive
cells by day 30 suggested that there was a reduction in acute
inflammatory response and that the electrospun collagen
scaffolds were biocompatible. Dense glial scar often forms
after SCI and hinders the regeneration of axons.53 However,
no obvious accumulation of GFAP-positive cells were de-
tected at the interface of the lesion site and the scaffolds,
indicating a possible decrease in astroglial scar formation in
the presence of collagen implants. One possible reason may
be the suppressive nature of collagen nanofibers over astro-
cyte proliferation seen in vitro.
When treated with collagen, some neural fiber sprouting
was observed in both groups as early as day 10. However,
the organization and orientation of regenerated axons in
response to nanofiber alignment were not obvious at either
time point. Markedly linear axonal regeneration was ob-
served inside aligned electrospun conduits using microfibers
with diameter of 1.2–1.6mm after 2-week implantation in a
complete transection SCI model.20 In addition, the influences
of fiber diameter on axonal outgrowth have been observed
by in vitro studies and larger diameter fibers (*1.3 mm) eli-
cited longer neurite outgrowth than smaller diameter fibers
(*290 nm).54 Taken together, these results suggested that
larger fiber diameter may have more significant influence on
axonal outgrowth. The diameter of collagen fibers used in
this study was 208.2– 90.4 nm. This smaller diameter could
be a possible reason for the insignificant difference in ori-
entation of regenerated neural fibers in vivo in response to
fiber orientation. However, the exact effect of fiber diameter
on the guidance of axonal outgrowth in vivo needs to be
elucidated in further works. In addition, due to the limited
sample size in this study, the exact trend of neural fiber
orientation in response to fiber alignment may not be eli-
cited. Future works involving larger number of animals may
help shed light in this area. Electrospun nanofibers may be
easily functionalized through protein incorporation to pro-
vide synergistic topographical and biochemical signaling to
enhance nerve regeneration.15 Further works involving
neurotrophin incorporation within collagen electrospun
scaffolds may also be conducted for enhanced nerve regen-
eration in SCI.
1064 LIU ET AL.
Conclusions
This study investigated the feasibility of using collagen
electrospun fibers for SCI treatment. Collagen nanofibers
suppressed astrocyte proliferation and GFAP expression, and
supported and directed DRG neurite outgrowth in vitro.
Preliminary in vivo studies showed that collagen electrospun
fibers diminished astrocyte accumulation at the lesion site,
provided a permissive environment for cellular infiltration
and supported neural fiber sprouting. These findings clearly
demonstrate the potential of electrospun collagen scaffolds
for SCI repair.
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